Published in Hepatitis Weekly, November 24th, 2003
Data from ongoing clinical and observational studies were presented at the 54th annual meeting of the American Association for the Study of Liver Diseases (AASLD).
A poster entitled "A phase I/II Study to Evaluate the Pharmacokinetics, Safety, Tolerability, Immunogenicity, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.